Respiratory Research and Treatment (RRT) is an international, peer-reviewed, open-access journal dedicated to advancing research in respiratory pathophysiology, evidence-based therapeutics, and their integrated applications for pulmonary health. Published quarterly online by GOSP, the journal bridges fundamental discoveries with clinical practice to address global challenges in respiratory disease management and public health.

Open Access Policy‌:
All articles in Respiratory Research and Treatment are freely accessible under a full Open Access model. To encourage global knowledge exchange, the journal currently imposes ‌no Article Processing Charges (0 APC)‌ for authors.

‌Rapid Publication Timeline‌:

  • ‌Peer Review Efficiency‌: Manuscripts undergo rigorous peer review, with initial decisions provided to authors within ‌21 days‌ of submission.
  • ‌Acceptance to Publication‌: Accepted papers are published online within ‌14 days‌ of final acceptance, ensuring timely dissemination of critical engineering advancements.

‌Reviewer Recognition Program‌:
Reviewers who deliver timely, thorough, and constructive evaluations receive ‌APC Discount Vouchers‌ as acknowledgment of their contributions. These vouchers may be applied to reduce fees for future submissions in any journal within the GOSP network, fostering a collaborative scholarly community.

Scope and Vision:

Respiratory Research and Treatment focuses on established and emerging research across pulmonary medicine, critical care, and respiratory science. Key areas include:

  • Pathophysiological mechanisms of airway diseases (COPD, asthma, pulmonary fibrosis, infections)
  • Advanced diagnostic approaches (imaging technologies, biomarker validation, genomic profiling)
  • Therapeutic developments in pharmacology, biologics, and regenerative medicine
  • Interventional techniques (bronchoscopy, ventilation management, device-based therapies)
  • Preventive medicine and population health strategies for respiratory disorders

The journal serves as a platform for interdisciplinary collaboration, connecting basic scientists, clinicians, and public health experts to address global challenges in antimicrobial resistance, environmental lung diseases, health disparities, and respiratory pandemic response.